Market research reports on: DNA, RNA, proteomics, genomics, genetics, cancer, cell, protein, sequencing, biomarkers, peptides, in vitro diagnostics, molecular and others.
Get a Quote274 Reports in Cell Biology
Genetic Modification Therapies Clinical Applications: Gene Thera...
The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.
Biomarkers: Technologies and Global Markets
The global market for biomarkers should grow from $78.9 billion in 2018 to $136.5 billion by 2023 at a compound annual growth rate (CAGR) of 11.6% from 2018 through 2023.
Next Generation Sequencing for Non-invasive Prenatal Testing: Glo...
The global market for non-invasive prenatal testing (NIPT) should grow from $1.9 billion in 2018 to reach $3.1 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2018-2023.
Global Markets for Enzymes in Industrial Applications
The global industrial enzymes market should reach $7.0 billion by 2023 from $5.5 billion in 2018 at a compound annual growth rate (CAGR) of 4.9% for the period 2018-2023.
Switching to CRISPR-Cas Systems from Uncultivated Microbes
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is currently the biggest discovery in life science. As a precise gene editing tool, it has been widely used in many areas with a great potential to treat human diseases. While some CRISPR-based therapeutic studies are moving to clinical trials, CRISPR's therapeutic promise was brought into question when some issues were found that could become major obstacles in moving the great genome editing tools to the clinic.While many groups are actively resolving these obstacles, the significant challenges to minimize the immunological risks and avoid potential tumorgenicity have received more attention as big concerns for CRISPR-Cas therapeutics advancing toward the clinic. We believe it is timely to summarize and analyze the emerging immunological risk and potential tumorgenicity with the CRISPR-Cas systems, to predict how this exciting genome editing market will affect other related segments of the entire life science market in the next few years. We also hope our opinion could serve as a "crowd crystal" on those discussions in response to the issues, and bring a better market environment for the technology to be sharpened and advanced into clinical applications.
Current Research & Developments Status of Chimeric Antigen Recept...
The global market for Chimeric Antigen Receptor (CAR) T-cell therapies will grow from nearly $467.0 million in 2018 to $2.9 billion by 2023 at a compound annual growth rate (CAGR) of 44.1% for the period of 2018-2023.
Adoptive Transfer of Autologous Lymphocytes Targeting Somatically...
Adoptive Cell Therapies (ACTs) and the infusion of autologous or redirected tumor-specific T-cells have the potential to drastically impact the treatment of a variety of cancers, especially common epithelial cancers. This report summarizes the current state of clinical research and trials, explains the impact of ACTs on the treatment of several metastasized malignancies, and also raises important concerns about the scalability and compatibility of TILs.
Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnosti...
The global market for polymerase chain reaction (PCR) in point of care (POC) diagnostics totaled $2.9 billion in 2018 and is estimated to reach $4.8 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.6% for the period of 2018-2023.
Microbial Products: Technologies, Applications and Global Markets
The global microbes and microbial products market should reach $302.4 billion by 2023 from $186.3 billion in 2018 at a compound annual growth rate (CAGR) of 10.2% for the period 2018-2023.
Immunohistochemistry (IHC): Global Markets to 2022
The global immunohistochemistry market totaled $1.6 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.8% for the period of 2017-2022.
Global Markets for Media, Sera and Reagents in Biotechnology
The global market for media, sera and reagents in biotechnology should reach $5.5 billion by 2023 from $4.1 billion in 2018 at a compound annual growth rate (CAGR) of 6.0% for the period 2018-2023.
Synthetic Biology: Global Markets
The global market for synthetic biology will grow from nearly $4.4 billion in 2017 to $13.9 billion by 2022, with a compound annual growth rate (CAGR) of 26.0% for the period of 2017-2022.
Cardiac Biomarkers: Technologies and Global Markets
The global market for cardiac biomarker will grow from $6.3 billion in 2017 to $9.9 billion by 2022, at a compound annual growth rate (CAGR) of 9.5% for the period of 2017-2022
Digital Polymerase Chain Reaction (PCR) Technology: Global Market...
The global digital polymerase chain reaction (PCR) technology market totaled $425.0 million in 2017 and is estimated to reach $746.0 million by 2022, growing at a compound annual growth rate (CAGR) of 11.9% for the period of 2017-2022.
Exosome Diagnostics and Therapeutics: Global Markets
The global market for exosome industry should reach $180.0 million by 2023 from $25 million in 2018 at a compound annual growth rate (CAGR) of 48.4% for the period 2018-2023.
The Chinese Market for DNA Sequencing
The Chinese market for DNA sequencing totaled $1.2 billion in 2017. The market should total $2.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 19.0% during 2017-2022.
Artificial Blood: Global Markets to 2027
The global market for potential artificial blood is estimated to grow from nearly $6.2 billion in 2022 to $15.6 billion by 2027 with a compound annual growth rate (CAGR) of 20.5% for the period of 2022-2027.
Biosimilars: Global Markets
The global biosimilars market reached nearly $5.5 billion in 2017 and is expected to reach $20.8 billion by 2022, with a compound annual growth rate (CAGR) of 30.5% from 2017 through 2022.
Cell Therapy Processing: Global Markets and Technologies
The global market for cell therapy reached $1.3 billion in 2017 and should reach $5.0 billion in 2022 at a compound annual growth rate (CAGR) of 30.9% for the period of 2017-2022.
The Global Market for Stem Cells
The global market for stem cells totaled $7.4 billion in 2017 and is estimated to reach $14.8 billion by 2022, growing at a compound annual growth rate (CAGR) of 14.7% for the period of 2017-2022.
Biologics Development and Manufacturing Testing: Technologies and...
The global biological safety testing market should reach $13.1 billion by 2022 from $5.1 billion in 2017 at a compound annual growth rate (CAGR) of 20.9%, from 2017 to 2022.
Mobile Apps for DNA Sequencing: Global Markets
The global market for mobile applications for DNA sequencing reached $28.8 billion in 2017. The market should reach $248.3 billion by 2022, at a compound annual growth rate (CAGR) of 53.8% during 2017-2022.
Drug Discovery Technologies
The global market for drug discovery technologies totaled $54.7 billion in 2017. The market should reach $85.8 billion by 2022, growing at a compound annual growth rate (CAGR) of 9.4% during 2017-2022.
Global Markets for Research Antibodies
The global market for research antibodies should reach $3.0 billion by 2022 from $2.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.8%, from 2017 to 2022.
Single-cell Omics: Emerging Technologies and Markets
The global single-cell omics market is expected to grow from $555.3 million in 2017 to nearly $1.6 billion in 2022, at a compound annual growth rate (CAGR) of 23.5% from 2017 to 2022.
Choose your License
5 Upcoming Reports in Cell Biology
3D Cell Cultures: Technologies and Global Markets
Examine 3D cell cultures technologies with current market status, future market drivers and its growth potential over the five-year period from 2019 to 2024.
Immunoassays: Technologies and Global Markets
Get an overview of global market for cell and gene therapy tools and information on their importance in treating human health.
Artificial Intelligence (AI) in Cancer
Detailed review of artificial intelligence (AI) applications in the diagnosis and treatment of cancer diseases. Coverage of different AI algorithm types -- artificial neural networks and deep learning -- and their feasible healthcare applications in the field of cancer
Artificial Intelligence (AI) in HIV/AIDS
An overview of the artificial intelligence (AI) applications in fighting against HIV/AIDS-related illnesses. Discussion of recent achievements and breakthrough therapies related to HIV/AIDS disease segments.
Next Generation Cancer Diagnostics: Technologies and Global Markets
Report Inludes
- An overview of the global market and technologies for next generation cancer diagnostics
- Analyses of global market trends, with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Analyses of the diagnostics market by cancer type, diagnostic purpose, analysis type, technology platform and region
- Evaluation of market status, impact on future and market forecast of the cancer diagnostics industry
- Discussion on factors affecting the market including cancer diagnostics needs, regulatory trends, industry structure, and patent statuses
- Profiles of key companies in the industry